|
Identification of microproteins (MPs) to generate cancer vaccines. ALBA (Antigens for Liver and Breast Anticancer vaccines).
|
0011-1411-2024-000077
|
GOVERNMENT OF NAVARRA
|
University of Navarra
|
2024 GN STRATEGIC PROJECTS OF RESEARCH AND DEVELOPMENT 2024-2027
|
12-06-2024
|
72.010,00€
|
-
|
|
Microplastics and microbiota in cardiometabolic health: innovative BIOlogical solutions for TOXIC DETECTION and prevention (BioDETOX).
|
0011-1411-2024-000069
|
GOVERNMENT OF NAVARRA
|
Foundation for Applied Medical research
|
FIMA 2024 GN STRATEGIC research and development PROJECTS 2024-2027
|
12-06-2024
|
566.656,90€
|
-
|
|
Technology platform to identify, develop and deliver gene therapy vectors to combat genetic kidney diseases: Treatment of autosomal dominant polycystic kidney disease subject II (TEGER).
|
0011-1411-2024-000121
|
GOVERNMENT OF NAVARRA
|
Foundation for Applied Medical research
|
FIMA 2024 GN STRATEGIC research and development PROJECTS 2024-2027
|
12-06-2024
|
440.062,42€
|
-
|
|
Identification of microproteins (MPs) to generate cancer vaccines. ALBA (Antigens for Liver and Breast Anticancer vaccines)
|
0011-1411-2024-000108
|
GOVERNMENT OF NAVARRA
|
Foundation for Applied Medical research
|
FIMA 2024 GN STRATEGIC research and development PROJECTS 2024-2027
|
12-06-2024
|
872.650,03€
|
-
|
|
Computational and experimental methods for adaptive neuromodulation for gait dysfunctions in Parkinson¿s disease.
|
0011-0537-2023-000062
|
GOVERNMENT OF NAVARRA / DPTO. EDUCATION CULTURE AND TOURISM
|
Foundation for Applied Medical research
|
FIMA GNE 2023 PREDOCTORAL FELLOWSHIPS
|
15-05-2024
|
74.142,00€
|
-
|
|
Novel strategies of targeted therapy and immunotherapy for the treatment of small cell lung cancer.
|
0011-0537-2023-000112
|
GOVERNMENT OF NAVARRA / DPTO. EDUCATION CULTURE AND TOURISM
|
Foundation for Applied Medical research
|
FIMA GNE 2023 PREDOCTORAL FELLOWSHIPS
|
15-05-2024
|
38.525,60€
|
-
|
|
BVARRIER: Blood vessels heterogenity restricting immune effector recruitmen.
|
0011-0537-2023-000050
|
GOVERNMENT OF NAVARRA / DPTO. EDUCATION CULTURE AND TOURISM
|
Foundation for Applied Medical research
|
FIMA GNE 2023 PREDOCTORAL FELLOWSHIPS
|
15-05-2024
|
46.023,75€
|
-
|
|
Diverging HFpEF Phenotypes : patient-tailoreD targeting of anti-Inflammatory pathways to limit Ventricular and Atrial remodelling.
|
49
PCI2024-153490
|
STATE INVESTIGATION AGENCY
|
Foundation for Applied Medical research
|
ERA4HEALTHCVD CARDINNOV 23: Research targeting development of innovative therapeutic strategies in cardiovascular disease¿.
|
13-05-2024
|
198.750,00€
|
-
|
|
Chair University business (Chair CHIP): design microelectronic wireless battery-less sensors
|
TSI-069200-2023-0001
|
Other national
|
University of Navarra
|
Chairs University-business "Chairs CHIP"
|
07-05-2024
|
192.953,97€
|
-
|
|
IBERIFIER Plus: Iberian Digital average Observatory.
|
101158511
|
EUROPEAN COMMISSION
|
University of Navarra
|
DIGITAL-2023-DEPLOY-04-EDMO-HUBS
|
28-04-2024
|
248.971,25€
|
-
|
|
FOXO as a central axis in DMG response to therapy.
|
S-80026-07 01 [2024-255763]
|
SWISS NATIONAL SCIENCE FOUNDATION (SNSF)
|
Foundation for Applied Medical research
|
Swiss National Science Foundation (SNSF) 2024
|
21-04-2024
|
61.020,00€
|
-
|
|
IMPLEMENTATION OF THE DIGITAL RIGHTS CHARTER IN THE CREATION OF THE DIGITAL RIGHTS OBSERVATION SPACE
|
C043-23-OT
|
PUBLIC BUSINESS ENTITY NETWORK.ES, M.P.
|
University of Navarra
|
2023 NETWORK.EN
|
03-04-2024
|
64.000,00€
|
-
|
|
Sustainable functional materials for 3D printing from Recycled oriGen for the Electrochemical sector (3DGREEN)
|
KK-2024/00009
|
EUSKO JAURLARITZA - BASQUE GOVERNMENT
|
University of Navarra
|
ELKARTEK 2024 research Projects with high industrial potential
|
01-04-2024
|
74.390,00€
|
-
|
|
RNA-based cancer ImmunotheraPeutics to Enhance CROssPrimming
|
101142365
|
EUROPEAN COMMISSION
|
Foundation for Applied Medical research
|
HORIZON-ERC-2023-ADG
|
25-03-2024
|
2.411.500,00€
|
-
|
|
PORTRAIT. A multi-omic stratification and a non-invasive tool for early recognition of triple negative and
Her2+ breast cancer patients responders to neoadjuvant therapy.
|
0011-2750-2022-000000
|
GOVERNMENT OF NAVARRA
|
University of Navarra
|
2022 GN ERA PERMED
|
22-03-2024
|
311.184,00€
|
-
|
|
Artificial induction of tertiary lymphoid structures (TLS) in tumors using intratumoral mRNAs to evaluate its synergy with immune checkpoint inhibitors
|
101149181
|
EUROPEAN COMMISSION
|
Foundation for Applied Medical research
|
HORIZON-MSCA-2023-PF-01
|
28-02-2024
|
181.152,96€
|
-
|
|
GNE 2020 PREDOC JOSE ANGEL OCHOA M. VALENCIA
|
0011-0537-2020-000089
|
GOVERNMENT OF NAVARRA / DPTO. EDUCATION CULTURE AND TOURISM
|
Foundation for Applied Medical research
|
FIMA GNE 2020 PREDOCTORAL FELLOWSHIPS
|
14-02-2024
|
3.557,20€
|
-
|
|
SPatial Analysis of Cancer Evolution in the Tumour Immune MicroEnvironment.
|
101136552
|
EUROPEAN COMMISSION
|
Foundation for Applied Medical research
|
HORIZON-MISS-2023-CANCER-01
|
14-02-2024
|
619.650,00€
|
-
|
|
EMPOWERED, INNOVATIVE AND ENTERPRISING 21ST CENTURY FORESTS
|
BF217
|
BIODIVERSITY FOUNDATION
|
University of Navarra
|
2023 FD Biodiversity. Projects for the promotion of the bioeconomy and contribution to the ecological transition.
|
08-02-2024
|
112.442,95€
|
MRR Funds
|
|
WHGD Women¿s Health Goes Digital
|
101134732
|
EUROPEAN COMMISSION
|
University of Navarra
|
ERASMUS KA2-Partnerships for Cooperation submitted by European NGOs
|
01-01-2024
|
57.000,00€
|
-
|
|
INC-STEP
|
|
EUROPEAN COMMISSION
|
University of Navarra
|
Third Party Project Grant Contract (3PP Contract) under the TETTRIs Project (Grant Agreement N° 101081903)
|
01-01-2024
|
38.214,68€
|
-
|
|
Projection Methods for Device Error Mitigation (ZNEProDEM)
|
|
EUSKO JAURLARITZA - BASQUE GOVERNMENT
|
University of Navarra
|
Ikur Strategy IBM Projects
|
01-01-2024
|
52.258,00€
|
-
|
|
Ikerbasque Permanent Position: Naiara Rodríguez Florez
|
|
IKERBASQUE BASQUE FOUNDATION FOR SCIENCE
|
University of Navarra
|
Permanent Positions 2023 IKERBASQUE
|
01-01-2024
|
42.788,77€
|
-
|
|
Advancing Additive Manufacturing of Metallic Components high performing : Ecodesign and Environmental Impact assessment (ADDILANZA)
|
|
AQUITAINE-EUSKADI-NAVARRE EUROREGION
|
University of Navarra
|
EUROREGIONAL INNOVATION 2023
|
01-01-2024
|
18.500,00€
|
-
|
|
GENEURONA. Implementation of genomic diagnosis of epilepsy and migraine in Navarra.
|
0011-1411-2018-000044
|
GOVERNMENT OF NAVARRA
|
Foundation for Applied Medical research
|
2018- GN PROJECTS. STRATEGIC research and development PROJECTS 2018-2020
|
31-12-2023
|
6.499,81€
|
-
|
|
INTELLIGENT PLATFORM and CYBERSEGURE FOR ADAPTIVE OPTIMIZATION IN SIMULTANEOUS OPERATION OF AUTONOMOUS ROBOTS
HETEROGENEOUS
|
PLEC2023-010353
|
STATE INVESTIGATION AGENCY
|
University of Navarra
|
2023 AEI Transmissions (CDTI)
|
22-12-2023
|
345.582,00€
|
MRR Funds
|
|
Human flourishing to prevent depression: longitudinal analysis of the SUN cohort.
|
PI23/01332
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
high school of research Sanitaria de Navarra - IdiSNA
|
2023 AES Projects research
|
20-12-2023
|
95.000,00€
|
ERDF funds
|
|
Dissecting the Role of the Immune Microenvironment in Myelodysplastic Syndromes.
|
RYC2022-036673-I
|
STATE INVESTIGATION AGENCY
|
University of Navarra
|
2022 AEI RAMÓN Y CAJAL
|
20-12-2023
|
314.350,00€
|
ESF Funds
|
|
Deciphering the mechanisms of resistance to radiotherapy in lung cancer. New opportunities for radiosensitizing therapies (RYC2022-038084-I).
|
RYC2022-038084-I
|
STATE INVESTIGATION AGENCY
|
University of Navarra
|
2022 AEI RAMÓN Y CAJAL
|
20-12-2023
|
244.350,00€
|
MRR Funds
|
|
European Digital Innovation Hub of Navarre - IRIS
|
A696-2023-485450400013
|
MINISTRY OF INDUSTRY AND TOURISM
|
University of Navarra
|
2023 MINTUR Program to Support Digital Innovation Hubs
|
19-12-2023
|
109.368,00€
|
Next Generation EU Funds
|
|
development of RNA-based tools for the treatment of genetic encephalopathies
|
24/2023
|
GOVERNMENT OF NAVARRA. DEPARTMENT OF HEALTH
|
Foundation for Applied Medical research
|
FIMA 2023 GOB. NAVARRA HEALTH
|
18-12-2023
|
79.925,00€
|
-
|
|
assessment ultra-sensitive and minimally invasive myeloid neoplasms by integrated single-cell techniques
|
PI23/01331
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
high school of research Sanitaria de Navarra - IdiSNA
|
2023 AES Projects research
|
18-12-2023
|
240.000,00€
|
ERDF funds
|
|
development of a new tool for the prediction of premature mortality based on lifestyle, cognitive function and molecular biomarkers of aging.
|
GN19/2023
|
GOVERNMENT OF NAVARRA. DEPARTMENT OF HEALTH
|
high school of research Sanitaria de Navarra - IdiSNA
|
2023 GN Projects of research in health
|
18-12-2023
|
77.510,00€
|
-
|
|
Human bioengineering for the detection and analysis of cardiovascular toxicity secondary to anti-oncology therapies. Sex factor analysis.
|
GN32/2023
|
GOVERNMENT OF NAVARRA. DEPARTMENT OF HEALTH
|
high school of research Sanitaria de Navarra - IdiSNA
|
2023 GN Projects of research in health
|
18-12-2023
|
79.925,00€
|
-
|
|
Elikia study. Sustainable screening for cervical cancer: HPV detection by pooling of vaginal samples obtained by autotoma and co-diagnosis of other sexually transmitted infections.
|
32-2023
|
GOVERNMENT OF NAVARRA. DEPARTMENT OF HEALTH
|
high school of research Sanitaria de Navarra - IdiSNA
|
2023 GN Projects of research in health
|
18-12-2023
|
79.154,07€
|
-
|
|
Identification of factors involved in the response to radioimmunotherapy in advanced non-small cell lung cancer.
|
PI23/01727
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
high school of research Sanitaria de Navarra - IdiSNA
|
2023 AES Projects research
|
18-12-2023
|
140.000,00€
|
ERDF funds
|
|
Mechanisms underlying the therapeutic effect of aerobic exercise in Parkinson¿s disease.
|
PI23/01701
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
high school of research Sanitaria de Navarra - IdiSNA
|
2023 AES Projects research
|
18-12-2023
|
115.000,00€
|
ERDF funds
|
|
Characterization of hemostatic alterations in patients receiving CAR-T cell therapy and their relationship with thrombotic and hemorrhagic complications. development
of thrombotic and hemorrhagic complications.
|
PI23/00890
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
high school of research Sanitaria de Navarra - IdiSNA
|
2023 AES Projects research
|
18-12-2023
|
90.000,00€
|
ERDF funds
|
|
Role of the MMP14/GDF15 axis in obesity-related metabolic alterations and their interaction with age.
|
PI23/00208
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
high school of research Sanitaria de Navarra - IdiSNA
|
2023 AES Projects research
|
18-12-2023
|
177.500,00€
|
ERDF funds
|
|
Immunotherapy with CAR-T cells against stromal antigens for the treatment of PDAC
|
AC23_1/00005
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
high school of research Sanitaria de Navarra - IdiSNA
|
2023 AES Projects of partnership international
|
18-12-2023
|
235.950,00€
|
-
|
|
IDENTIFICATION OF TRANSCRIPTIONAL MECHANISMS OF PROGRESSION AND RESISTANCE TO TREATMENT IN PATIENTS WITH HIGH-RISK MYELODYSPLASTIC
PATIENTS WITH HIGH RISK MYELODYSPLASTIC SYNDROMES
|
PI23/00516
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
high school of research Sanitaria de Navarra - IdiSNA
|
2023 AES Projects research
|
18-12-2023
|
228.750,00€
|
ERDF funds
|
|
Characterization of Chronic Spontaneous Urticaria Based on Response to Antihistamines: Approach to Intracellular Signaling Molecules.
|
PI23/01280
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
high school of research Sanitaria de Navarra - IdiSNA
|
2023 AES Projects research
|
18-12-2023
|
215.000,00€
|
ERDF funds
|
|
Conditional co-stimulation through 4-1BB exploiting Crosspriming in cancer CONDICOS
|
CPP2022-009762
|
STATE INVESTIGATION AGENCY
|
University of Navarra
|
2022 AEI PARTNERSHIP PUBLIC PRIVATE
|
18-12-2023
|
184.763,20€
|
MRR Funds
|
|
essay Phase I clinical trial of a new antifibrinolytic agent, compound CM-352, with an efficient synthesis route, aimed at the control of disabling and lethal bleeding.
|
CPP2022-009643
|
STATE INVESTIGATION AGENCY
|
University of Navarra
|
2022 AEI PARTNERSHIP PUBLIC PRIVATE
|
18-12-2023
|
1.161.981,80€
|
MRR Funds
|
|
DSTYK inhibition as the basis for a novel targeted therapy to break resistance to standard treatments in lung cancer
|
PI23/00223
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
Foundation for Applied Medical research
|
FIMA 2023 AES research Projects
|
18-12-2023
|
177.500,00€
|
ERDF funds
|
|
RYC2022-036689-I K.VALENCIA
|
RYC2022-036689-I
|
MINISTRY OF SCIENCE, INNOVATION AND UNIVERSITIES
|
Foundation for Applied Medical research
|
FIMA 2022 MCIU RAMÓN Y CAJAL
|
14-12-2023
|
244.350,00€
|
ESF Funds
|
|
RYC2022-036819-I M. MONTES
|
RYC2022-036819-I
|
MINISTRY OF SCIENCE, INNOVATION AND UNIVERSITIES
|
Foundation for Applied Medical research
|
FIMA 2022 MCIU RAMÓN Y CAJAL
|
14-12-2023
|
244.350,00€
|
ESF Funds
|
|
RYC2022-036929-I RAFAEL VALDES
|
RYC2022-036929-I
|
MINISTRY OF SCIENCE, INNOVATION AND UNIVERSITIES
|
Foundation for Applied Medical research
|
FIMA 2022 MCIU RAMÓN Y CAJAL
|
14-12-2023
|
244.350,00€
|
ESF Funds
|
|
assessment of neutron dose in a proton therapy facility: implications for the pediatric patient and worker.
|
PI23/00157
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
high school of research Sanitaria de Navarra - IdiSNA
|
2023 AES Projects research
|
14-12-2023
|
127.500,00€
|
ERDF funds
|
|
Exploring the anti-aging effects of Metformin in COPD
|
ICI23/00049
|
HIGH SCHOOL CARLOS III HEALTH CENTRE
|
high school of research Sanitaria de Navarra - IdiSNA
|
2023 AES research Independent Clinic
|
14-12-2023
|
396.000,00€
|
ERDF funds
|
|
|
|
|
|
|
|
|
